Results 1 to 10 of about 117,026 (248)

Meningioma: Novel Diagnostic and Therapeutic Approaches

open access: yesBiomedicines
Background/Objectives: Meningiomas are the most common intracranial tumors. Surgery and radiation therapy are the cornerstones of treatment and no standard of care therapy exists for refractory meningiomas. This manuscript aims to provide a comprehensive
Carlen A. Yuen   +3 more
doaj   +1 more source

Somatostatin Analogs in the Medical Management of Occult Bleeding of the Lower Digestive Tract

open access: yesGastroenterology Research and Practice, 2015
The management of occult bleeding from the lower digestive tract can be very challenging. In cases of identified angiodysplasia, the first line management options can be limited by a number of clinical or anatomical factors and an alternative approach ...
Julie Martin-Grace, Gianluca Tamagno
doaj   +1 more source

Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias

open access: yesCurrent Issues in Molecular Biology
Somatostatin is a peptide that plays a variety of roles such as neurotransmitter and endocrine regulator; its actions as a cell regulator in various tissues of the human body are represented mainly by inhibitory effects, and it shows potent activity ...
Argyrios Periferakis   +12 more
doaj   +1 more source

The influence of somatostatin analogues on the incidence of pancreatic fistulas and postoperative morbidity in patients undergoing pancreatic resection: A Bayesian network meta-analysis.

open access: yesPLoS ONE
BackgroundPancreatic resection is a critical treatment for pancreatic cancer and other pancreatic diseases. Somatostatin analogs are commonly used to prevent complications following pancreatic resection, but their efficacy and safety remain debated ...
Zonghao Hou   +5 more
doaj   +1 more source

Long-Term Disease Control of a Non-Operable Neuroendocrine Tumor of the Lung with Lanreotide: A Case Study

open access: yesCase Reports in Oncology, 2012
Bronchopulmonary neuroendocrine tumors (NETs) are malignant tumors that represent approximately 20% of all lung cancers. The therapeutic option for advanced or metastatic bronchopulmonary NETs is mainly palliation of symptoms; options need to be ...
F. Van Fraeyenhove   +8 more
doaj   +1 more source

Somatostatin analogs: Future directions [PDF]

open access: yesMetabolism, 1996
Lamberts, S. W.J.   +3 more
openaire   +2 more sources

Expression of somatostatin receptors in hemangioblastomas associated with von Hippel-Lindau disease as a novel diagnostic, therapeutic, and follow-up opportunity: A case report and literature review

open access: yesArchives of Endocrinology and Metabolism
SUMMARY Hemangioblastomas associated with von Hippel-Lindau (VHL) disease are frequently multiple and recur during prolonged follow-up. Currently, no systemic treatment is available for these tumors.
Eloá Pereira Brabo   +4 more
doaj   +1 more source

Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis

open access: yesJournal of Ophthalmology, 2018
Purpose. Numerous medical strategies have been proposed for the treatment of thyroid eye disease (TED); however, the best methods for standard treatment are still a matter of controversy.
Nuo Xu, Yi Cui, Tianlu Xie, Mi Zheng
doaj   +1 more source

Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets

open access: yesBMC Cancer, 2017
Background Hepatocellular (HCC) and cholangiocellular carcinomas (CCC) display an exceptionally poor prognosis. Especially for advanced disease no efficient standard therapy is currently available.
Daniel Kaemmerer   +8 more
doaj   +1 more source

On implications of somatostatin in diabetic retinopathy

open access: yesNeural Regeneration Research
Somatostatin, a naturally produced neuroprotective peptide, depresses excitatory neurotransmission and exerts anti-proliferative and anti-inflammatory effects on the retina.
Yanhong Fang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy